Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Journal of General Internal Medicine
Published in: Journal of General Internal Medicine 11/2019

01-11-2019 | Underweight | Concise Research Reports

Overweight and Obese Have Similar Burden of Hip Fracture as Normal Weight Older Adults

Authors: Jennifer T. Lloyd, PhD, MA, MS, Shari R. Waldstein, PhD, Marc C. Hochberg, MD, MPH, Denise L. Orwig, PhD, Dawn E. Alley, PhD

Published in: Journal of General Internal Medicine | Issue 11/2019

Login to get access

Excerpt

The association between body weight and fracture risk is a significant public health concern as the majority of older adults are overweight or obese and have low mineral density.1 Osteoporotic fractures are projected to cost $25 billion in health care spending annually by 2025, with hip fractures accounting for over 70% of these costs.2 Post-fracture spending is 25% higher among obese individuals.3 …
Literature
1.
Nielson CM, Srikanth P, Orwoll E. Obesity and fracture in men and women: An epidemiologic perspective. J Bone Miner Res. 2012;27(1):1–10.CrossRef
2.
Burge R, Dawson-Hughes B, Solomon DH, et al. Incidence and economic burden of osteoporosis-related fractures in the United States, 2005-2025. J Bone Miner Res. 2007;22(3):465–475.CrossRef
3.
Schousboe JT, Paudel ML, Taylor BC, et al. Pre-fracture individual characteristics associated with high total health care costs after fracture. Osteoporos Int. 2017; 28(8): 889–899.CrossRef
4.
Cawley J, Burkhauser RV. Beyond BMI: the Value of More Accurate Measures of Fatness and Obesity in Social Science Research. Cambridge: National Bureau of Economic Research; 2006:1–50.CrossRef
5.
Leveille SG, Wee CC, Iezzoni LI. Trends in obesity and arthritis among baby boomers and their predecessors, 1971-2002. Am J Public Health. 2005;95(9):1607–1613.CrossRef
6.
Himes CL, Reynolds SL. Effect of Obesity on Falls, Injury, and Disability. JAGS. 2012; 60:124–29.CrossRef
Metadata
Title
Overweight and Obese Have Similar Burden of Hip Fracture as Normal Weight Older Adults
Authors
Jennifer T. Lloyd, PhD, MA, MS
Shari R. Waldstein, PhD
Marc C. Hochberg, MD, MPH
Denise L. Orwig, PhD
Dawn E. Alley, PhD
Publication date
01-11-2019
Publisher
Springer US
Published in
Journal of General Internal Medicine / Issue 11/2019
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-019-05151-y

Other articles of this Issue 11/2019

Journal of General Internal Medicine 11/2019 Go to the issue

Concise Research Reports

Exploring Institutional Practices to Develop Faculty Evaluators: Results from the 2016 Clerkship Directors in Internal Medicine National Survey

Concise Research Reports

Rate of Plagiarism in Personal Comments Essays of Applicants to a US Allopathic Medical School: an Observational Study

Original Research

Statin Dosing Instructions, Medication Adherence, and Low-Density Lipoprotein Cholesterol: a Cohort Study of Incident Statin Users

OriginalPaper

Sexual Orientation and Patient-Provider Communication About Sexual Problems or Concerns Among US Adults

Original Research

“You Guys Really Care About Me…”: a Qualitative Exploration of a Produce Prescription Program in Safety Net Clinics

Original Research

Prevalence of Activity Limitations and Association with Multimorbidity Among US Adults 50 to 64 Years Old
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits